179 related articles for article (PubMed ID: 30014288)
1. Immunohistochemistry for PAX7 is a useful confirmatory marker for Ewing sarcoma in decalcified bone marrow core biopsy specimens.
Fernandez-Pol S; van de Rijn M; Natkunam Y; Charville GW
Virchows Arch; 2018 Dec; 473(6):765-769. PubMed ID: 30014288
[TBL] [Abstract][Full Text] [Related]
2. PAX7 immunohistochemical evaluation of Ewing sarcoma and other small round cell tumours.
Toki S; Wakai S; Sekimizu M; Mori T; Ichikawa H; Kawai A; Yoshida A
Histopathology; 2018 Oct; 73(4):645-652. PubMed ID: 29920735
[TBL] [Abstract][Full Text] [Related]
3. Image-guided core needle biopsy for Ewing sarcoma of bone: a 10-year single-institution review.
Kalus S; Vidoni A; Oliveira I; Saifuddin A
Eur Radiol; 2020 Oct; 30(10):5308-5314. PubMed ID: 32468104
[TBL] [Abstract][Full Text] [Related]
4. [Small cell malignant tumors of bone: comparison between diagnosis using core needle biopsies and surgical specimens].
Ding Y; Xi Y; Sun XQ; Meng SQ; Liu WF; Huang XY
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):163-7. PubMed ID: 23769434
[TBL] [Abstract][Full Text] [Related]
5. FLI-1 distinguishes Ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma.
Lee AF; Hayes MM; Lebrun D; Espinosa I; Nielsen GP; Rosenberg AE; Lee CH
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):233-8. PubMed ID: 21084965
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors.
Machado I; Yoshida A; López-Guerrero JA; Nieto MG; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2017 Sep; 213(9):1048-1053. PubMed ID: 28864350
[TBL] [Abstract][Full Text] [Related]
7. PAX7 Expression in Rhabdomyosarcoma, Related Soft Tissue Tumors, and Small Round Blue Cell Neoplasms.
Charville GW; Varma S; Forgó E; Dumont SN; Zambrano E; Trent JC; Lazar AJ; van de Rijn M
Am J Surg Pathol; 2016 Oct; 40(10):1305-15. PubMed ID: 27526298
[TBL] [Abstract][Full Text] [Related]
8. Does PAX7 and NKX2.2 immunoreactivity in Ewing sarcoma have prognostic significance?
Machado I; Charville GW; Yoshida A; Navarro S; Righi A; Gambarotti M; Scotlandi K; López-Guerrero JA; Llombart-Bosch A
Virchows Arch; 2022 Apr; 480(4):909-917. PubMed ID: 34985580
[TBL] [Abstract][Full Text] [Related]
9. Liquid Biopsies in Ewing Sarcoma.
Krumbholz M; Metzler M
Methods Mol Biol; 2021; 2226():39-45. PubMed ID: 33326092
[TBL] [Abstract][Full Text] [Related]
10. Screening of BCOR-CCNB3 sarcoma using immunohistochemistry for CCNB3: A clinicopathological report of three pediatric cases.
Shibayama T; Okamoto T; Nakashima Y; Kato T; Sakurai T; Minamiguchi S; Kataoka TR; Shibuya S; Yoshizawa A; Toguchida J; Haga H
Pathol Int; 2015 Aug; 65(8):410-4. PubMed ID: 26037154
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow.
Dubois SG; Epling CL; Teague J; Matthay KK; Sinclair E
Pediatr Blood Cancer; 2010 Jan; 54(1):13-8. PubMed ID: 19711435
[TBL] [Abstract][Full Text] [Related]
12. Round cell sarcoma with CIC-DUX4 gene fusion: Discussion of the distinctive cytomorphologic, immunohistochemical, and molecular features in the differential diagnosis of round cell tumors.
Chebib I; Jo VY
Cancer Cytopathol; 2016 May; 124(5):350-61. PubMed ID: 26800124
[TBL] [Abstract][Full Text] [Related]
13. BCOR-CCNB3 (Ewing-like) sarcoma: a clinicopathologic analysis of 10 cases, in comparison with conventional Ewing sarcoma.
Puls F; Niblett A; Marland G; Gaston CL; Douis H; Mangham DC; Sumathi VP; Kindblom LG
Am J Surg Pathol; 2014 Oct; 38(10):1307-18. PubMed ID: 24805859
[TBL] [Abstract][Full Text] [Related]
14. NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls.
Russell-Goldman E; Hornick JL; Qian X; Jo VY
Cancer Cytopathol; 2018 Nov; 126(11):942-949. PubMed ID: 30376220
[TBL] [Abstract][Full Text] [Related]
15. Adding Perplexity to Rarity: Diffuse S100-Protein and SOX10 Expression in a Molecularly Confirmed PAX7-Positive Primary Cutaneous Ewing Sarcoma.
Parra O; Thuraisingam R; Baker ML; Kerr DA; Linos K
Am J Dermatopathol; 2021 Dec; 43(12):984-989. PubMed ID: 34132666
[TBL] [Abstract][Full Text] [Related]
16. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.
Syed M; Mushtaq S; Loya A; Hassan U
Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of nestin expression in pediatric tumors in the region of the kidney.
Murphy AJ; Viero S; Ho M; Thorner PS
Appl Immunohistochem Mol Morphol; 2009 Dec; 17(6):517-23. PubMed ID: 19417621
[TBL] [Abstract][Full Text] [Related]
18. (Immuno)histological Analysis of Ewing Sarcoma.
Marcilla D; Machado I; Grünewald TGP; Llombart-Bosch A; de Álava E
Methods Mol Biol; 2021; 2226():49-64. PubMed ID: 33326093
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of FLI-1 protein expression in Ewing Sarcoma/ peripheral primitive neuroectodermal tumour: A study of 50 cases.
Ahmed S; Hashmi SN;
J Pak Med Assoc; 2016 Oct; 66(10):1296-1298. PubMed ID: 27686307
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of PHOX2B in primary and treated neuroblastoma and in neuroblastoma metastatic to the bone marrow.
Hata JL; Correa H; Krishnan C; Esbenshade AJ; Black JO; Chung DH; Mobley BC
Arch Pathol Lab Med; 2015 Apr; 139(4):543-6. PubMed ID: 25822764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
